These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35628517)

  • 21. [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis].
    Abramowicz A; Gos M
    Postepy Hig Med Dosw (Online); 2015 Dec; 69():1331-48. PubMed ID: 26671924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
    Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
    Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF1, Neurofibromin and Gene Therapy: Prospects of Next-Generation Therapy.
    Cui XW; Ren JY; Gu YH; Li QF; Wang ZC
    Curr Gene Ther; 2020; 20(2):100-108. PubMed ID: 32767931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
    Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
    Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.
    Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H
    J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
    De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
    Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient.
    Fu Y; Zhang JQ; Jiang CL; Wang HY
    J Dermatol; 2018 Aug; 45(8):986-988. PubMed ID: 29952103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofibromin in the brain.
    Gutmann DH
    J Child Neurol; 2002 Aug; 17(8):592-601; discussion 602-4, 646-51. PubMed ID: 12403558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofibromatosis type 1 revisited.
    Williams VC; Lucas J; Babcock MA; Gutmann DH; Korf B; Maria BL
    Pediatrics; 2009 Jan; 123(1):124-33. PubMed ID: 19117870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
    Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
    Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.
    Jeong SY; Park SJ; Kim HJ
    J Korean Med Sci; 2006 Feb; 21(1):107-12. PubMed ID: 16479075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubility survey of fragments of the neurofibromatosis type 1 protein neurofibromin.
    Bonneau F; Lenherr ED; Pena V; Hart DJ; Scheffzek K
    Protein Expr Purif; 2009 May; 65(1):30-7. PubMed ID: 19111619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
    Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
    Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
    Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
    Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
    Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
    Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two pathogenic NF1 gene mutations identified in DNA from a child with mild phenotype.
    Terzi YK; Sirin B; Hosgor G; Serdaroglu E; Anlar B; Aysun S; Ayter S
    Childs Nerv Syst; 2012 Jun; 28(6):943-6. PubMed ID: 22159552
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molecular genetic diagnosis of neurofibromatosis type I].
    Polgár N; Komlósi K; Hadzsiev K; Illés T; Melegh B
    Orv Hetil; 2011 Mar; 152(11):415-9. PubMed ID: 21362601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative splicing of the neurofibromatosis type I pre-mRNA.
    Barron VA; Lou H
    Biosci Rep; 2012 Apr; 32(2):131-8. PubMed ID: 22115364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.